Tag Archives: FDA

US Created Drug Problem by Overdoing ADHD, Drugs

As we hear of more and more drug overdoses, kids in addiction treatment, marijuana psychosis and sudden deaths with designer drugs, we need to ask how did the United States get itself into such a mess? How did we send our youth down this dangerous path?

Between 1979 and 1992 marijuana usage among American teens went down. The Parents Movement and “Just Say No” campaign had an impact. What has gone wrong since that time?
We can look to a few big changes in the 1990s:

1) In 1990, President George H. W. Bush signed the Americans with Disabilities Act, a landmark piece of legislation that encouraged inclusiveness and has made life better for a large number of people with disabilities. CHADD, a group representing people with Attention Deficit Disorder lobbied successfully Continue reading US Created Drug Problem by Overdoing ADHD, Drugs

Legalization is not Inevitable

Marijuana is Not Winning in Court or in the State Governments

1) Responsible Ohio had put together investors to get marijuana on the ballot in 2015. Secretary of State is not accepting the signatures and that there will not be enough signatures by the deadline: “ResponsibleOhio raised nearly $1.7 million during the first half of the year from investors with a stake in the marijuana growing sites outlined in its proposed constitutional amendment. Almost all donations from the entities were for $50,000 or more,” according to an article in the Cannabist.  Many signatures were not legitimate. 

2) In California, a Northern California appeals court ruled that marijuana businesses cannot deduct business expenses on their tax returns.

3) Journal of the American Medical Association  (JAMA) published a major study to say Medical Marijuana would not meet the requirements of FDA approval. Continue reading Legalization is not Inevitable

American Epilepsy Association Statement on CBD Oils

The following letter was written by Dr. Amy Brooks-Kayal to a state representative in Pennsylvania.  Here is an article where the letter had been published.

March 22, 2015

Dear Representative,

As Pennsylvania considers enacting new cannabis legislation (HB 193), I write to offer the perspective of the American Epilepsy Society (AES), the leading U.S. organization of clinical and research professionals specializing in the treatment and care of people with epilepsy. Continue reading American Epilepsy Association Statement on CBD Oils

Governor of Idaho Allows CBD Trial Medicine

Boise_IdahoOn  April 16, 2015, Governor Butch Otter of Idaho issued an executive order authorizing the Department of Health and Welfare to implement an FDA-approved expanded access program for treatment-resistant epilepsy in children.

He vetoed a bill that would have allowed a non-pharmacy grade of cannabidiol oil (CBD) to be purchased through an uncontrolled system from questionable sources. Instead, the governor decided upon a plan allowing children with intractable epilepsy to access Epidiolex, a pure, pharmaceutical-grade of CBD, through an FDA-approved clinical trial. Continue reading Governor of Idaho Allows CBD Trial Medicine